A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma

Liverpool Hospital, Liverpool

University of Zurich Medical School, Zurich

Memorial Sloan Kettering Cancer Center Mskcc, New York

Penn State Milton S Hershey Medical Center, Hershey

Thomas Jefferson University Hospital Jefferson Health, Philadelphia

University of Virginia, Charlottesville

Tennessee Oncology, Pllc Nashville, Nashville

Ohio State University, Columbus

Cleveland Clinic Foundation, Cleveland

Henry Ford Hospital, Detroit

Washington University in St Louis, St Louis

Midamerica Division, Inc, Kansas City

Sarah Cannon Research Institute (Scri) Stephenson Cancer Center, Oklahoma City

Sarah Cannon Research Institute (Scri) At Health One, Denver

Huntsman Cancer Institute, Salt Lake City

Center For Neurosciences, Tucson

UCLA, Los Angeles

University of California At San Francisco, San Francisco

Institut Gustave Roussy, Villejuif

Massachusetts General Hospital, Boston

Dana Farber Cancer Institute, Boston

Universitair Medisch Centrum Utrecht, Utrecht